Select for export Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0069 PubMed 40051480 Copy citation Copy BibTeX Psychedelic Medicine 2024-05-07 Anthony L. Back, Susanna Myers, John Guy, Juliana Pérez, Leslie Lazar Thorn, Bonnie A. McGregor OpenAlex Published psilocybin Clinical TrialSafety Clinical Trial More
Select for export EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmj.q1025 PubMed 38704154 Copy citation Copy BibTeX BMJ 2024-05-03 British Medical Journal Publishing Group OpenAlex Published psilocybin DepressionClinical TrialMeta-Analysis Meta-Analysis More
Select for export From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine Abstract available at the source but not redistributed here. Read at source. Details DOI 10.59324/ejahss.2024.1(3).10 Copy citation Copy BibTeX European Journal of Arts Humanities and Social Sciences 2024-04-30 Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12888-024-05768-2 PubMed 38658877 Copy citation Copy BibTeX BMC Psychiatry 2024-04-24 Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen OpenAlex Published psilocybin Chronic PainBrain ImagingMechanism of Action Clinical Trial More
Select for export MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.05.5.1 Copy citation Copy BibTeX Psychiatric News 2024-04-22 Terri D’Arrigo OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-04-18 Section for Affective Disorders; Northern Stockholm Psychiatry ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-58318-x PubMed 38632313 Copy citation Copy BibTeX Scientific Reports 2024-04-16 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Psychedelic therapists, pharma collaborate on clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/mhw.34009 Copy citation Copy BibTeX Mental Health Weekly 2024-04-12 Valerie A. Canady OpenAlex Published psilocybin Clinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psychedelics and the ‘inner healer’: Myth or mechanism? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241239206 PubMed 38605658 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-04-11 Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export Who will staff the psychedelic resurgence? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.56367/oag-042-10690 Copy citation Copy BibTeX Open Access Government 2024-04-08 Erika Dyck OpenAlex Published psilocybin DepressionAddictionClinical Trial Clinical Trial More
Select for export The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/15563650.2024.2346612 PubMed 38753585 Copy citation Copy BibTeX Clinical Toxicology 2024-04-01 Rachael Wilkes, Darren M. Roberts, Paul Liknaitzky, Jonathan Brett OpenAlex Published psilocybin Clinical TrialObservational StudyHealthcare Workers Clinical Trial More
Select for export Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.jns.2024.122993 PubMed 38581739 Copy citation Copy BibTeX Journal of the Neurological Sciences 2024-04-01 Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher Gottschalk, L. Taylor Flynn, Yutong Zhu, Brian Pittman OpenAlex Published psilocybin Chronic PainHeadache / MigrainePharmacology Randomized Controlled Trial More
Select for export Microdosing psychedelics in the treatment of ADHD and comorbid disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.44 Copy citation Copy BibTeX European Psychiatry 2024-03-31 Kim P. C. Kuypers OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Clinical Trial More
Select for export The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/dddt.s443177 PubMed 38618282 Copy citation Copy BibTeX Drug Design Development and Therapy 2024-03-31 Sarah A. Norring, Michael G. Spigarelli OpenAlex Published psilocybin PharmacologyClinical TrialObservational Study Clinical Trial More
Select for export MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.1 Copy citation Copy BibTeX Psychiatric News 2024-03-25 Terri D’Arrigo OpenAlex Published psilocybin AnxietyPharmacologyClinical Trial Clinical Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psychedelic Renaissance: Evidence and Culture Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.39 Copy citation Copy BibTeX Psychiatric News 2024-03-20 Adrian Preda OpenAlex Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psychedelic drugs and the law: What’s next? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/knowable-031424-2 Copy citation Copy BibTeX Knowable Magazine 2024-03-13 Ben Seal OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Systematic Review More
Select for export The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0300501 PubMed 38483940 Copy citation Copy BibTeX PLoS ONE 2024-03-13 Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener OpenAlex Published psilocybin DepressionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11469-024-01253-9 Copy citation Copy BibTeX International Journal of Mental Health and Addiction 2024-03-06 Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
